Etoposide
Hepatosplenic T-Cell Lymphoma
City of Hope Medical CenterSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Hepatosplenic T-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Isocyclophosphamide Shandong Provincial Hospital | Phase 4 | BBB |
Adriamycin National Cancer Institute (NCI) | Phase 4 | BBB |
Fludarabine National Cancer Institute (NCI) | Phase 2 | BBB |
Prednisone City of Hope Medical Center | Phase 4 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Etoposide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →